Clinical Trial Update: Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes [NA]

View source ↗

Summary

A clinical trial in Lyon evaluating novel biomarkers of disease progression and clinical outcomes in patients with type 2 diabetes and metabolic dysfunction-ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Metabolic Dysfunction-Associated Liver Disease | NA | Status: RECRUITING